Avastin联合化疗治疗8例晚期肿瘤病人的护理
Nurisng care of 8 cases with late stage tumor treated by Avastin combination chemotherapy
出处
《护理研究》
2005年第4期636-637,共2页
Chinese Nursing Research
参考文献5
-
1Ferrara N. Vascular endothelial growth factor: Basic science and clinical progress [J]. Endocr Rev, 2004,25 (4): 581 - 611.
-
2Hurwitz. Bevacizumab prolongs survival in first - line colorectal cancer (CRC): Results of a phase Ⅲ trial of bevacizumab in combination with bolus IFL as first- line therapy in subjects with metastatic CRC[M]. Proc: ASCO,2003:3646.
-
3Hurwitz. Phase Ⅱ, randomized trial comparing bevacizumab plus fluorouracil (FU)/leucovorin (LV) with FU/LV alone in patients with metastatic colorectal cancer[M]. Proc: ASCO, 2003: 3646.
-
4Chen H X. Expanding the clinical development of bevacizumab [J].The Oncologist, 2004,9(Suppl 1) :27 - 35.
-
5Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizurnab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer[J]. N EnglJMed,2004,350(23):2335 - 2342.
-
1金飞燕.结肠直肠癌治疗药 贝伐单抗(bevacizumab)[J].世界临床药物,2006,27(6):379-379. 被引量:2
-
2于冰.探究肝癌治疗靶点与肝靶向抗癌药物的研究进展[J].生物技术世界,2015,12(7):138-138. 被引量:1
-
3上市新药[J].世界临床药物,2013,34(11).
-
4韩铭(综述),邓华瑜(审校).曲妥珠单抗在乳腺癌中的耐药机制研究进展[J].中华医学教育探索杂志,2011,10(9):1150-1152.
-
5任文晓,江泽飞,宋三泰.bevacizumab治疗乳腺癌的基础和临床研究[J].国际肿瘤学杂志,2006,33(8):600-602.
-
6曹璐,杨昭志,陈佳艺.乳腺癌放疗联合曲妥珠单抗的心脏毒性与保护研究进展[J].中华放射肿瘤学杂志,2013,22(1):84-86. 被引量:1
-
7赵红,李小龙,崔洁,冯谢敏,宋炜.曲妥珠单抗治疗胃癌的研究进展[J].延安大学学报(医学科学版),2012,10(1):25-27. 被引量:4
-
8流小舟,吴苏稼,施鑫.贝伐单抗在骨肉瘤治疗中的研究进展[J].江苏医药,2012,38(14):1698-1700.
-
9活性物好但往往药品差[J].德国临床用药,1999,2(4):43-45.
-
10抗癌新法“饿死”癌细胞[J].中老年保健,2009(6):6-6.